Illumina, Inc. balance sheet

At the end of fiscal 2025, Illumina, Inc. had total assets of $6.64bn and shareholders' equity of $2.72bn. It held $1.42bn in cash against $1.99bn of debt: net debt of $571m.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Illumina, Inc.: balance sheet, annual
Fiscal year	2009Jan 2010	2010Jan 2011	2011Jan 2012	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Jan 2016	2016Jan 2017	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Jan 2021	2021Jan 2022	2022Jan 2023	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Cash and equivalents	0.1	0.2	0.3	0.4	0.7	0.6	0.8	0.7	1.2	1.1	2.0	1.8	1.2	2.0	1.0	1.1	1.4	1.3
Receivables	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.4	0.4	0.5	0.6	0.5	0.6	0.7	0.7	0.7	0.9	0.7
Inventory	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.3	0.4	0.4	0.4	0.4	0.6	0.6	0.5	0.6	0.7
Total current assets	1.0	1.3	1.5	1.8	1.6	1.9	2.1	2.3	3.0	4.5	4.5	4.5	2.7	3.6	2.6	2.7	3.3	3.0
Goodwill	0.2	0.3	0.3	0.4	0.7	0.7	0.8	0.8	0.8	0.8	0.9	0.9	7.1	3.2	2.5	1.1	1.1	1.3
Total assets	1.4	1.8	2.2	2.6	3.0	3.3	3.7	4.3	5.3	7.0	7.3	7.6	15.2	12.3	10.1	6.3	6.6	6.8
Accounts payable	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.2	0.2	0.2
Deferred revenue (current)	—	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.3
Total current liabilities	0.4	0.5	0.2	0.3	0.3	0.7	0.6	0.7	0.7	1.8	0.7	1.2	1.1	2.8	1.6	1.5	1.6	1.2
Short-term debt	0.3	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.5	0.0	—	—	—	—	—
Long-term debt	—	—	—	—	—	1.0	1.0	1.1	1.2	0.8	1.1	0.7	1.0	1.5	1.5	1.5	1.5	1.8
Total debt	0.3	0.3	0.8	1.0	0.9	1.5	1.1	1.1	1.2	2.0	1.1	1.2	1.0	2.7	1.5	2.0	2.0	1.8
Shareholders' equity	0.9	1.2	1.1	1.3	1.5	1.5	1.8	2.2	2.7	3.8	4.6	4.7	10.7	6.6	5.7	2.4	2.7	3.1
Net debt (negative = net cash)	0.1	0.1	0.5	0.5	0.2	0.8	0.3	0.3	−0.0	0.9	−0.9	−0.6	−0.2	0.7	0.4	0.9	0.6	0.5
Shares outstanding	—	127m	122m	124m	128m	144m	147m	146m	147m	147m	147m	146m	157m	158m	159m	159m	153m	—

US$ millions unless shown otherwise. Fiscal quarters.

Illumina, Inc.: balance sheet, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Receivables	735	699	701	729	854	738	764	738
Inventory	547	537	575	590	564	611	629	667
Total current assets	2,746	2,673	2,641	2,796	3,289	2,738	2,834	3,035
Goodwill	1,113	1,113	1,113	1,113	1,113	1,284	1,284	1,284
Total assets	6,303	6,182	6,087	6,177	6,644	6,559	6,650	6,812
Accounts payable	221	207	200	218	240	218	230	241
Deferred revenue (current)	260	256	247	234	270	269	261	250
Total current liabilities	1,547	1,440	1,461	1,962	1,585	1,566	1,578	1,156
Long-term debt	1,490	1,491	1,492	994	1,490	1,490	1,491	1,789
Total debt	1,490	1,491	1,492	994	1,490	1,490	1,491	1,789
Shareholders' equity	2,373	2,368	2,258	2,381	2,723	2,676	2,838	3,145
Shares outstanding	159m	—	—	—	153m	—	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ILMN vs WAT ILMN vs MTD CRL vs ILMN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Illumina, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Illumina, Inc.